Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 4Lung Neoplasms 2Tongue Neoplasms 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Laryngeal Neoplasms 1Hypoxia 1Hypopharyngeal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 4Radiotherapy 3Riluzole 2Ipilimumab 2Drug Therapy 2Counseling 2Carboplatin 2Bupropion 2Blood Specimen Collection 2vofatamab 1utomilumab 1trastuzumab deruxtecan 1tocilizumab 1spartalizumab 1sargramostim 1pazopanib 1liposomal doxorubicin 1ixabepilone 1fostamatinib 1fluoromisonidazole 1erythromycin propionate-N-acetylcysteinate 1cemiplimab 1brodalumab 1aldesleukin 1Zinc Oxide 1Varenicline 1Topotecan 1Tobacco Use Cessation Devices 1Tissue Banks 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × fluoromisonidazole × Head & Neck × Clear all
NCT01213030 2012-09-25

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Siemens Molecular Imaging

Phase 1/2 Completed
12 enrolled
GastrointestinalHead & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡